Regentatlantic Capital LLC Danaher Corp Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Danaher Corp stock. As of the latest transaction made, Regentatlantic Capital LLC holds 33,439 shares of DHR stock, worth $7.89 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

33,439

Previous 32,766 2.05%

Holding current value

$7.89 Million

Previous $8.31 Million 3.97%

% of portfolio

0.26%

Previous 0.27%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $166,271 - $1.01 Million	673 Added 2.05%	33,439 $8.64 Million
Q2 2022 Aug 15, 2022	BUY	$237.11 - $299.66 $96,029 - $121,362	405 Added 1.25%	32,766 $8.31 Million
Q1 2022 May 02, 2022	BUY	$257.27 - $315.76 $238,489 - $292,709	927 Added 2.95%	32,361 $9.49 Million
Q4 2021 Jan 27, 2022	SELL	$292.08 - $329.01 $35,049 - $39,481	-120 Reduced 0.38%	31,434 $10.3 Million
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $131,477 - $160,563	-483 Reduced 1.51%	31,554 $9.61 Million
Q2 2021 Aug 12, 2021	SELL	$225.08 - $271.69 $79,903 - $96,449	-355 Reduced 1.1%	32,037 $8.6 Million
Q1 2021 Apr 29, 2021	BUY	$212.38 - $245.9 $217,689 - $252,047	1,025 Added 3.27%	32,392 $7.29 Million
Q4 2020 Feb 04, 2021	BUY	$212.5 - $245.46 $243,525 - $281,297	1,146 Added 3.79%	31,367 $6.97 Million
Q3 2020 Oct 13, 2020	SELL	$177.16 - $215.33 $389,929 - $473,941	-2,201 Reduced 6.79%	30,221 $6.51 Million
Q2 2020 Aug 13, 2020	BUY	$128.7 - $176.83 $200,385 - $275,324	1,557 Added 5.04%	32,422 $5.73 Million
Q1 2020 May 14, 2020	SELL	$121.39 - $169.05 $246,057 - $342,664	-2,027 Reduced 6.16%	30,865 $4.27 Million
Q4 2019 Feb 04, 2020	SELL	$133.47 - $153.48 $260,399 - $299,439	-1,951 Reduced 5.6%	32,892 $5.05 Million
Q3 2019 Oct 22, 2019	SELL	$135.4 - $146.47 $131,608 - $142,368	-972 Reduced 2.71%	34,843 $5.03 Million
Q2 2019 Jul 23, 2019	SELL	$124.88 - $143.73 $223,285 - $256,989	-1,788 Reduced 4.75%	35,815 $5.12 Million
Q1 2019 May 03, 2019	BUY	$97.62 - $132.29 $53,691 - $72,759	550 Added 1.48%	37,603 $4.96 Million
Q4 2018 Jan 30, 2019	BUY	$94.85 - $109.54 $190,458 - $219,956	2,008 Added 5.73%	37,053 $3.82 Million
Q3 2018 Oct 30, 2018	BUY	$98.13 - $108.9 $3,532 - $3,920	36 Added 0.1%	35,045 $3.81 Million
Q2 2018 Jul 31, 2018	SELL	$96.1 - $103.24 $130,311 - $139,993	-1,356 Reduced 3.73%	35,009 $3.46 Million
Q1 2018 Apr 23, 2018	SELL	$92.16 - $103.8 $137,226 - $154,558	-1,489 Reduced 3.93%	36,365 $3.56 Million
Q4 2017 Jan 23, 2018	SELL	$85.26 - $94.62 $153,297 - $170,126	-1,798 Reduced 4.53%	37,854 $3.51 Million
Q3 2017 Oct 25, 2017	BUY	$79.29 - $88.45 $3.14 Million - $3.51 Million	39,652	39,652 $3.4 Million

Others Institutions Holding DHR

# of Institutions

2,508

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Danaher Corp Transaction History